GASTRIC CANCER NEWS TIPS & FEATURES


OMNI Health Media is a leading online provider of Daily Health News. OMNI’s Gastric Cancer News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.
Diagnosed with Gastric Cancer: 10 Tips on How to Get The Most From Your Doctor

December 21, 2017

Diagnosed with Gastric Cancer: 10 Tips on How to Get The Most From Your Doctor

By Anonymous User anonymous_user_10987

1) Choose Your Doctor Carefully Surgeons, medical oncologists and radiation oncologists are the primary doctors involved with gastric cancer and often work in collaboration. Pick your primary oncologist carefully, rely on people you trust including nurses and other health care professionals who make help with recommendations.  Make sure your doctor is someone you feel comfortable […]

View full entry

Tags: Gastric Cancer, News Tips and Features, News Tips and Features Other


Does Long-term use of Proton Pump Inhibitors as Treatment for Ulcers Increases Risk for Gastric Cancer?

November 27, 2017

Does Long-term use of Proton Pump Inhibitors as Treatment for Ulcers Increases Risk for Gastric Cancer?

By cancerconnect cancerconnect

The use of a proton-pump inhibitor (PPI) medication after Helicobacter pylori eradication appears to more than doubles the risk for developing gastric cancer, according to a recent study published in the medical journal Gut.1 About Proton pump inhibitors. This group of drugs, which includes Nexium® (esomeprazole), Prevacid® (lansoprazole), Prilosec® (omeprazole), and others reduces stomach acidity by blocking […]

View full entry

Tags: esomeprazole, Gastric Cancer, gastric Ulcer, heliobacter pylori, lansoprazole, News Tips and Features, News Tips and Features Other, Nexium, omeprazole, Prevacid, Prilosec, proton pump inhibitors


New Standard of Care for Treatment of Resectable Gastric Cancer

October 3, 2017

New Standard of Care for Treatment of Resectable Gastric Cancer

By Anonymous User anonymous_user_10987

The superiority of docetaxel based triplet therapy over standard care in patients with resectable esophago-gastric cancer has been confirmed in late-breaking results from the FLOT4 trial presented at the ESMO 2017 Congress in Madrid.1 Survival in resectable esophago-gastric cancer is poor. Five-year overall survival is around 25% with surgery, and is increased to 36% by […]

View full entry

Tags: Esophageal Cancer, esophago-gastric cancer, Gastric Cancer, News Tips and Features, News Tips and Features Other


The US Food and Drug Administration has Expanded the Approval of the Precision Cancer Medicine Keytruda for Treatment of Gastric Cancer

September 25, 2017

The US Food and Drug Administration has Expanded the Approval of the Precision Cancer Medicine Keytruda for Treatment of Gastric Cancer

By Anonymous User anonymous_user_10987

Keytruda (Pembrolizumab) is now indicated for patients with recurrent locally advanced or metastatic gastric or gastro-esophogeal junction adenocarcinoma. Patients eligible for keytruda therapy under this new indication must have PD-L1-expressing tumors, and must demonstrate disease progression after two or more prior lines of therapy – including fluoropyrimidine- and platinum-containing chemotherapy and, in some cases, HER2/neu-targeted […]

View full entry

Tags: checkpoint inhibitor, Esophageal Cancer, Gastric Cancer, gastro-esophogeal junction cancer, keytruda, metastatic gastric, News Tips and Features, News Tips and Features Other, pembrolizumab, Precision Cancer Medicine


Keytruda Immunotherapy Appears Promising in Advanced Gastric Cancer

September 18, 2017

Keytruda Immunotherapy Appears Promising in Advanced Gastric Cancer

By Anonymous User anonymous_user_10987

Keytruda (pembrolizumab) appears promising in patients with pretreated metastatic gastric cancer, according to late-breaking results from the KEYNOTE-059 trial presented at the European Society for Medical Oncology (ESMO) 2017 Congress in Madrid.1 Stomach cancer (gastric cancer), is the third leading cause of cancer-related deaths worldwide. Overall, the 5-year survival rate for patients with gastric cancer […]

View full entry

Tags: Gastric Cancer, immunotherapy, KEYNOTE-059 programmed death-ligand 1, keytruda, metastatic gastric cancer, News Tips and Features, News Tips and Features Other, PD-L1, pembrolizumab, Precision Cancer Medicine, stomach cancer


Interim PET Scans May Improve Treatment for Esophageal Cancer

February 9, 2017

Interim PET Scans May Improve Treatment for Esophageal Cancer

By cancerconnect cancerconnect

Clinical trial results presented at the 2017 Gastrointestinal Cancers Symposium in San Francisco suggest that the use of PET scans to assess a cancers response to initial chemotherapy may provide doctors with useful information to further tailor chemotherapy. Standard treatment of patients with stage II-III esophageal and gastroesophageal junction (GEJ) cancers includes chemotherapy with radiation […]

View full entry

Tags: Esophageal Cancer, Gastric Cancer, News Tips and Features, News Tips and Features Other


Opdivo (nivolumab) Improves Survival in Patients with Advanced Gastric Cancer

February 6, 2017

Opdivo (nivolumab) Improves Survival in Patients with Advanced Gastric Cancer

By Anonymous User anonymous_user_10987

At the 2017 Gastrointestinal Cancers Symposium in San Francisco researchers presented new trial results demonstrating that Opdivo (nivolumab) significantly reduced the risk of death by 37% in patients with previously treated advanced gastric cancer refractory to or intolerant of standard therapy, a condition without current standard-of-care treatments. About Gastric Cancer Gastric cancer refers to cancer of the […]

View full entry

Tags: Gastric Cancer, immunotherapy, News Tips and Features, News Tips and Features Other, nivolumab, Opdivo, precision medicine


Proton Beam Therapy May Improve Outcomes for Esophageal Cancer

January 23, 2017

Proton Beam Therapy May Improve Outcomes for Esophageal Cancer

By Anonymous User anonymous_user_10987

Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. Radiation may be part of the treatment strategy for select cancers of the esophagus, anus, rectum, pancreatic, or small intestine. This treatment approach is often associated with improved outcomes but the radiation may also cause […]

View full entry

Tags: Esophageal Cancer, Gastric Cancer, News Tips and Features, News Tips and Features Other, Pancreatic Cancer, proton beam therapy, Recurrent Gastric Cancer, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer, Stage IV/Recurrent Esophageal Cancer, Stages I-II Gastric Cancer, Stages I-III Esophageal Cancer


View more articles like this
More news and in-depth Esophageal Cancer information

CONDITIONS OF THE GI TRACT